Surrozen (Surrozen) Research & Development : $24.39 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Surrozen Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Surrozen's Research & Development for the three months ended in Mar. 2024 was $5.25 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $24.39 Mil.

Surrozen Research & Development Historical Data

The historical data trend for Surrozen's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surrozen Research & Development Chart

Surrozen Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Research & Development

25.68

40.18

37.01

27.23

Surrozen Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial										8.09	6.94	6.11	6.10	5.25

Surrozen Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.39 Mil.

Surrozen (NAS:SRZNW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Surrozen Research & Development Related Terms

Thank you for viewing the detailed overview of Surrozen's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Surrozen (Surrozen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Surrozen Inc (NAS:SRZNW) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

SRZN:USA

Address

171 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

https://www.surrozen.com

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).